Baker David Charles 4
4 · Vallon Pharmaceuticals, Inc. · Filed Feb 12, 2021
Insider Transaction Report
Form 4
Baker David Charles
Director
Transactions
- Other
Common Stock
2021-02-12$6.40/sh+7,843$50,195→ 7,843 total - Purchase
Common Stock
2021-02-12$8.00/sh+1,000$8,000→ 8,843 total
Footnotes (1)
- [F1]Issued immediately prior to the closing of the initial public offering of the issuer's common stock in connection with the conversion of the promissory notes held by the reporting person, as disclosed in the prospectus, dated February 9, 2021, filed with the U.S. Securities and Exchange Commission on February 11, 2021, which forms a part of the Registration Statements on Form S-1 (File Nos. 333-249636 and 333-252925), originally filed on October 23, 2020, as amended.